CCL28 and cancer: Consistent with its tumorigenic functions, CCL28 expression levels from the Human Protein Atlas [9] are negatively correlated with survival rate in two of the three leading causes of cancer death in the United States [10], including pancreatic ductal adenocarcinoma (PDAC) [11,12] (Fig. 1A) and lung cancer [13].